Published on 20 Sep 2024 on GuruFocus.com · via Yahoo Finance
BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc.
Overview of BlackRock's Recent Transaction
On August 31, 2024, BlackRock Inc. (Trades, Portfolio), a prominent investment management firm, executed a significant transaction involving the reduction of its holdings in Emergent BioSolutions Inc. (NYSE:EBS). The firm sold 1,870,591 shares, resulting in a remaining total of 1,968,784 shares. This move, marked by a trade price of $8.31 per share, reflects a strategic adjustment in BlackRock's investment portfolio, despite the trade having a neutral impact on its overall position.
Profile of BlackRock Inc. (Trades, Portfolio)